MedPath

The use of carbon dioxide (CO2) as a contrast medium for performing endovascular procedures

Not Applicable
Recruiting
Conditions
ower limb ischemia caused by aortoiliac stenosis, lower limb ischemia due to stenosis of femoropopliteal Abdominal aortic aneurysm with an indication for endovascular repair.
I71.9
Registration Number
RBR-7v2vvt
Lead Sponsor
Hospital Israelita Albert Einstein
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with critical lower limb ischemia resulting from arterial disease morphology TASC A or B or abdominal aortic aneurysms with an indication for the correction ; Agreement and signing the informed consent.

Exclusion Criteria

Contraindications to any of the types of procedures either by the technique used, type of contrast or medical reasons.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improve / complete resolution of the patient's condition coupled with the technical feasibility of using carbon dioxide as a contrast medium for performing endovascular procedures for treating patients with vascular disease and lower incidence of side-effects, as evaluated by a lower incidence renal and allergic complications.
Secondary Outcome Measures
NameTimeMethod
Reduced costs of endovascular procedures for treating patients with vascular disease treated by National Health System (SUS), through the use of new contrast medium for lower cost.
© Copyright 2025. All Rights Reserved by MedPath